Fluorescence Guided Minimally-Invasive Resection Of Abdominal Paragangliomas Using Indocyanine Green

Last updated: December 1, 2023
Sponsor: Leiden University Medical Center
Overall Status: Active - Recruiting

Phase

N/A

Condition

Neuroendocrine Carcinoma

Treatment

Fluorescence guided identification using indocyanine green

Clinical Study ID

NCT06155734
nWMO_GLL_1
  • Ages > 18
  • All Genders

Study Summary

This study is exploring whether it's possible to detect paragangliomas (a rare type of tumor) during minimally invasive surgery by using a technique called near-infrared fluorescence imaging, guided by a substance called indocyanine green (ICG). The goal is to see if this method can help surgeons identify and treat paragangliomas more accurately and during minimally invasive procedures.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Diagnosed with abdominal paraganglioma and underwent minimally-invasive surgicalresection

Exclusion

Exclusion Criteria:

  • Open surgical procedures

Study Design

Total Participants: 6
Treatment Group(s): 1
Primary Treatment: Fluorescence guided identification using indocyanine green
Phase:
Study Start date:
November 11, 2023
Estimated Completion Date:
February 20, 2024

Connect with a study center

  • Leiden University Medical Center

    Leiden, 2300RC
    Netherlands

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.